Concepedia
Statistics
Publications
2
Citations
41
H-Index
Active since
2018
Affiliations
Shanghai Pulmonary Hospital(Current)
First Affiliated Hospital Zhejiang University
Jiangsu Hengrui Medicine (China)
Tongji University
Yi Na Wang is an author at Shanghai Pulmonary Hospital specializing in pharmacology, cancer pharmacology, and medicine.
Publications per year
2018–2019
Efficacy of PD-1 monoclonal antibody SHR-1210 plus apatinib in patients with advanced nonsquamous NSCLC with wild‐type EGFR and ALK.
Caicun Zhou, Guanghui Gao, Yi Na Wang et al. · Journal of Clinical Oncology · 2019 · 25 citations
Medicine, Oncology, Pharmacology +17
A phase Ib study of SHR-1210 plus apatinib for heavily previously treated advanced non-squamous non-small cell lung cancer (NSCLC) patients.
Caicun Zhou, Guanghui Gao, Fengying Wu et al. · Journal of Clinical Oncology · 2018 · 16 citations
Medicine, Oncology, Pharmacology +12
1–2 of 2